Braslyn Ltd.

Braslyn Ltd. discloses dealings in 2 companies, chiefly Mirati Therapeutics, Inc. and Inseego Corp. We count 75 filings; the first trade dates from 15 January 2016 and the latest from 10 March 2021.

On the open market, the record shows 20 purchases worth €9.4M and 41 sales worth €208.1M. On balance, insiders were net sellers of €198.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants and 7 option exercises. So far in 2021, the count stands at no purchases and 9 sales.

A typical purchase (the median) is worth €129k. On 12 out of 20 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 10 March 2021 came the latest disclosure, an open-market sale for €183k in Mirati Therapeutics, Inc. The latest purchase dates back some time: it was published 3,569 days ago, on 30 January 2017. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.